Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.6 USD | -1.27% | +10.12% | -4.19% |
08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.19% | 2.97B | |
+7.63% | 113B | |
+10.39% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.25% | 17.24B | |
+6.54% | 14.29B | |
+36.09% | 12.52B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Cowen Initiates Denali Therapeutics With Outperform Rating